Open-label Extension Study of Brazikumab in Ulcerative Colitis
A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (EXPEDITION OLE) A Phase 2 Open-label, Long-term Extension Safety Study of Brazikumab in Participants With Moderately ...